294
Participants
Start Date
October 11, 2016
Primary Completion Date
April 30, 2018
Study Completion Date
November 7, 2018
SAIT101
1,000 mg i.v. of SAIT101 on Day 1 and 15. 1,000 mg i.v. of SAIT101 on week 24 and 26 for eligible patients.
MabThera
1,000 mg i.v. of MabThera® on Day 1 and 15. 1,000 mg i.v. of MabThera® on week 24 and 26 for eligible patients.
Rituxan
1,000 mg i.v. of Rituxan® on Day 1 and 15. 1,000 mg i.v. of Rituxan® on week 24 and 26 for eligible patients.
Research Site, Budapest
Research Site, Budapest
Research Site, Sofia
Research Site, Sofia
Research Site-1, Plovdiv
Research Site-2, Plovdiv
Research Site, Anyang
Research Site, A Coruña
Research Site, A Coruña
Research Site, A Coruña
Research Site, Suwon
Research site, Bad Doberan
Research site, Hamburg
Research site, Rendsburg
Research Site, Fuenlabrada
Research Site, Orlando
Research Site, Tampa
Research Site, Tampa
Research Site, Durango
Research Site, Daejeon
Research Site, Anniston
Research site, Vogelsang
Research site, Ratingen
Research Site, Seville
Research Site, Seville
Research Site, Daegu
Research Site, Daegu
Research Site, Lansing
Research Site, Busan
Research Site, Busan
Research Site, Gwangju
Research Site, Jeju City
Research Site, Kansas City
Research site, Sarajevo
Research Site, Waco
Research Site, Boise
Research Site, Mostar
Research Site-1, Los Angeles
Research Site-2, Los Angeles
Research Site, Lakewood
Research Site, La Mesa
Research Site, El Cajon
Research Site, San Leandro
Research Site, Tacoma
Research site, Jaipur
Research site, Bikaner
Research site, Pune
Research site, Pune
Research site, Pune
Research site, Bangalore
Research site, Hubli
Research site, Kolkata
Research site, Brno
Research site, Ostrava
Research site, Prague
Research site, Uherské Hradiště
Research site, Dresden
Research Site, Mexico City
Research Site, Mexico City
Research site, Gdansk
Research site, Krakow
Research site, Krakow
Research site, Kłodzko
Research site, Nowa Sól
Research site, Oświęcim
Research site, Poznan
Research site, Poznan
Research site, Tychy
Research site, Warsaw
Research site, Warsaw
Research site, Wroclaw
Research site, Zamość
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Archigen Biotech Limited
INDUSTRY